Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Dose-Response Studies On Omega-3, Immune Function Needed - Researcher

This article was originally published in The Tan Sheet

Executive Summary

Dose-response studies are needed to evaluate the effects of omega-3 fatty acids on immune function and response, Philip Calder, PhD, University of Southampton, England, said at a May 17 workshop on macronutrients and immune function.

You may also be interested in...

Vitamins C, E, Selenium Upper Limits Set For First Time By FNB

The Institute of Medicine's Food & Nutrition Board announced selenium upper intake limits for the first time, setting the maximum safe intake amount at 400 mcg/day. The last review of safe and effective intake levels for antioxidants by the National Academy of Sciences group was in 1989.

Supplement GMP Warning Letters Make Modest Debut In 2010

Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC

People In Brief

Perrigo promotes in pricing, planning





Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts